MENU
OMER
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Omeros (OMER) Ownership - Who owns Omeros?

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
201 Elliott Avenue West
Phone
+1 206 676-5000
Employees
198
Web
https://www.omeros.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
283.11M
P/E Ratio
N/A
Total Cash
28.74M
Projected Growth
N/A
Total Debt
184.33M
Revenue
N/A
Risk (Beta)
3.19
Dividend Yield
N/A
Total Cash/Share
0.42
Total Debt/Equity
618.04
Revenue/Share
null USD as % of share price

Fundamentals

OMER
Capitalization
283M
P/E Ratio
N/A
Risk (Beta)
3.19
Dividend Yield
N/A
Total Cash
28.7M
Total Cash/Share
0.42
Total Debt
184M
Total Debt/Equity
618.04
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-228.68M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-2.11
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
599K
Current Ratio
0.81
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-125.18M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-43.99
Shares Held By Institutions
200M
Shares Outstanding - Current
68.1M
Total Liabilities
429M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-57.895
View a ticker or compare two or three
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. OMER showed earnings on August 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
201 Elliott Avenue West
Phone
+1 206 676-5000
Employees
198
Web
https://www.omeros.com